One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
Stopping Alzheimer's disease before symptoms start
doi : 10.1016/S1474-4422(26)00045-1
Volume 25, Issue 3, March 2026
Intensive rehabilitation after subacute spinal cord injury: more is not always better
A step towards antiepileptogenic therapies for post-stroke epilepsy
When Alzheimer's disease prevention becomes policy: regulatory speed, commercialisation, and risk
Alzheimer's disease and epileptic activity: uncertainties abound
Resolution of expression of concern—Serotonergic pathology and disease burden in the premotor and motor phase of A53T ?-synuclein parkinsonism: a cross-sectional study
Detection of phosphorylated ?-synuclein in skin – Authors' reply
Maria Pia Amato: focusing on cognitive health in multiple sclerosis
Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trial
Safety and efficacy of fordadistrogene movaparvovec in ambulatory participants with Duchenne muscular dystrophy (CIFFREO): a phase 3, double-blind, randomised, placebo-controlled study
Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial
A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA
Epileptic activity in Alzheimer's disease: emerging insights and therapeutic implications
Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGAD
